263 related articles for article (PubMed ID: 26942875)
21. Investigation of the Interaction between Aloe vera Anthraquinone Metabolites and c-Myc and C-Kit G-Quadruplex DNA Structures.
Dallavalle S; Artali R; Princiotto S; Musso L; Borgonovo G; Mazzini S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555657
[TBL] [Abstract][Full Text] [Related]
22. Detecting the formation of human c-KIT oncogene promoter G-Quadruplex by Taylor dispersion analysis.
Yang Y; Yang Y; Wang S; Li H; Chen DDY
Talanta; 2021 Oct; 233():122533. PubMed ID: 34215036
[TBL] [Abstract][Full Text] [Related]
23. G4 Sensing Pyridyl-Thiazole Polyamide Represses c-KIT Expression in Leukemia Cells.
Paul R; Dutta D; Das T; Debnath M; Dash J
Chemistry; 2021 Jun; 27(33):8590-8599. PubMed ID: 33851760
[TBL] [Abstract][Full Text] [Related]
24. A two-quartet G-quadruplex topology of human KIT2 is conformationally selected by a perylene derivative.
Ceschi S; Largy E; Gabelica V; Sissi C
Biochimie; 2020 Dec; 179():77-84. PubMed ID: 32949676
[TBL] [Abstract][Full Text] [Related]
25. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
26. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
27. Destabilisation of the c-kit1 G-quadruplex structure by N
Laddachote S; Nagata M; Yoshida W
Biochem Biophys Res Commun; 2020 Apr; 524(2):472-476. PubMed ID: 32008744
[TBL] [Abstract][Full Text] [Related]
28. Spectroscopic probing of recognition of the G-quadruplex in c-kit promoter by small-molecule natural products.
Cui X; Lin S; Yuan G
Int J Biol Macromol; 2012 May; 50(4):996-1001. PubMed ID: 22405847
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
30. Regulation of c-Kit gene transcription selectively by bisacridine derivative through promoter dual i-motif structures.
Gong X; Lin X; Wang S; Ji D; Shu B; Huang ZS; Li D
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194912. PubMed ID: 36754277
[TBL] [Abstract][Full Text] [Related]
31. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
32. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
33. Exploration of the Structure and Recognition of a G-quadruplex in the her2 Proto-oncogene Promoter and Its Transcriptional Regulation.
Cui X; Chen H; Zhang Q; Xu M; Yuan G; Zhou J
Sci Rep; 2019 Mar; 9(1):3966. PubMed ID: 30850693
[TBL] [Abstract][Full Text] [Related]
34. Specific Stabilization of c-MYC and c-KIT G-Quadruplex DNA Structures by Indolylmethyleneindanone Scaffolds.
Diveshkumar KV; Sakrikar S; Rosu F; Harikrishna S; Gabelica V; Pradeepkumar PI
Biochemistry; 2016 Jun; 55(25):3571-85. PubMed ID: 27226253
[TBL] [Abstract][Full Text] [Related]
35. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex.
Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS
Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.
Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A
ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016
[TBL] [Abstract][Full Text] [Related]
37. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator.
Morgan RK; Batra H; Gaerig VC; Hockings J; Brooks TA
Biochim Biophys Acta; 2016 Feb; 1859(2):235-45. PubMed ID: 26597160
[TBL] [Abstract][Full Text] [Related]
39. Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine.
Zhang L; Tan W; Zhou J; Xu M; Yuan G
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):884-891. PubMed ID: 28132898
[TBL] [Abstract][Full Text] [Related]
40. Phenanthroline-2,9-bistriazoles as selective G-quadruplex ligands.
Nielsen MC; Larsen AF; Abdikadir FH; Ulven T
Eur J Med Chem; 2014 Jan; 72():119-26. PubMed ID: 24361524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
